Toggle navigation
Home
Search
Services
Blog
Contact
About
Oral Antisense Therapy for Cancer
Manoharan, Muthiah
Isis Pharmaceuticals, Inc., Carlsbad, CA, United States
Search 8 grants from Muthiah Manoharan
Search grants from Isis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epigenetic and Transcriptional Dysregulation in Autism Spectrum Disorder
Administrative Core
Development of Ipdr as A Radiosensitizing Drug
Pinealocyte Gap Junctions
Biomedical Research Support
Recently added grants:
Study of queuosine salvage and function in eukaryotes; a forgotten micronutrient
Identification of novel splicing regulatory complexes
Local ancestry inference for complex admixtures
The histone deacetylase SIRT6 modulates Transcriptional pausing
Translational inhibition by Schlafen proteins during the DNA damage response
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA083543-01
Application #
6020093
Study Section
Special Emphasis Panel (ZRG1-SSS-1 (02))
Program Officer
Fu, Yali
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$123,990
Indirect Cost
Institution
Name
Isis Pharmaceuticals, Inc.
Department
Type
DUNS #
361949092
City
Carlsbad
State
CA
Country
United States
Zip Code
92010
Comments
Be the first to comment on Muthiah Manoharan's grant